Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Komorniki

4 clinical trials in Komorniki, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Komorniki at a glance
4
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

4 trials in Komorniki

Open in trial search
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Komorniki

What the registry says about research in the country

01 Komorniki
Cardiovascular Diseases
Clinical research in Komorniki is focused on cardiovascular diseases, with studies examining major conditions such as atherosclerotic cardiovascular disease, elevated Lp(a), peripheral arterial disease, and heart failure with preserved or mildly reduced ejection fraction linked to obesity. The trials are aimed at understanding how new approaches may help reduce risk and improve patient outcomes. Evaluating a potential therapy for reducing major cardiovascular events Studying treatment options for patients with elevated lipoprotein(a) Assessing support for people living with heart failure and obesity Exploring ways to improve walking ability in peripheral arterial disease This area reflects a strong emphasis on testing whether new treatments can better prevent complications and improve day-to-day functioning in people at risk of serious heart and vascular problems.
Respiratory Tract Diseases
Another key research area in Komorniki is respiratory tract disease, especially moderate to very severe chronic obstructive pulmonary disease. The ongoing trial activity is centered on finding better ways to control symptoms and reduce disease flare-ups in people living with this long-term lung condition. Testing a new treatment for chronic obstructive pulmonary disease Measuring whether it can lower the rate of worsening respiratory episodes Focusing on improved management of severe lung disease These studies are designed to evaluate how well emerging therapies may help patients breathe more easily and experience fewer exacerbations over time.
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.